SINGAPORE (Oct 30): Here are three positives and three negatives to take away from OCBC’s results, according to Phillip Capital analyst Jeremy Teong who is upgrading the lender to “buy” from “accumulate” with a higher target price of $13.48.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply